Enavate Sciences GP, LLC
CIK: 0001953107Latest portfolio: $506.8M · Q4 2025
Holdings
7
Total Value
$506.8M
New Positions
0
Closed Positions
0
Top Holdings
| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ZBIOZENAS BIOPHARMA INC | 3,919,159 | $142.3M | 28.08% | +158K | |
| 2 | IMNMIMMUNOME INC | 4,768,583 | $102.4M | 20.21% | — | |
| 3 | SIONSIONNA THERAPEUTICS INC | 2,478,030 | $101.9M | 20.12% | — | |
| 4 | UPBUPSTREAM BIO INC | 2,459,703 | $66.8M | 13.18% | — | |
| 5 | CMPXCOMPASS THERAPEUTICS INC | 7,788,150 | $41.8M | 8.25% | — | |
| 6 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 2,626,946 | $32.9M | 6.49% | — | |
| 7 | CAMPCAMP4 THERAPEUTICS CORP | 3,035,825 | $18.6M | 3.67% | -749,977 |
Sector Breakdown
Healthcare100.0% ($1.4230410242910194e+28T)
Filing History
Fund Information
Enavate Sciences GP, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $506.8M across 7 holdings. The largest position is ZENAS BIOPHARMA INC (ZBIO), representing 28.1% of the portfolio. Compared to the previous quarter, the fund opened 0 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.